A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to characterize the delayed-type hypersensitivity (DTH) response at the site of Candin intradermal injection in the presence of a targeted immune pathway inhibitor.
Epistemonikos ID: a876949867ede694b8bed4028ccf5bbe9bf2f555
First added on: May 09, 2024